Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Common Patenting Tactic by Drug Companies May Be Illegal, F.T.C. Says

Experts say the exploitation of a loophole in the patent system has contributed to high prices for inhalers.

Rebecca Robbins
Author: Rebecca Robbins

Written by

Rebecca Robbins

in

Antitrust Laws and Competition Issues, Content Type: Service, Drugs (Pharmaceuticals), Federal Trade Commission, Generic Brands and Products, Inventions and Patents, Regulation and Deregulation of Industry
←Reporter Seems To Badmouth Bills Star Stefon Diggs On Hot Mic And Apologizes For It
The Bloomingdale’s Big Brown Bag Turns 50→

More posts

  • Protesters, leaders push back against DHS over Newark detention facility conditions

  • Goldman and Lander spar hard over Israel

  • Snowflake climbs after Q1 results top expectations, guidance gets a boost

  • Synopsys drops despite better than expected Q2 results, big boost to full-year guidance

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube